Country/territory: United Kingdom (UK)
Sector:
Corporate
The articles listed below published by authors from AstraZeneca, organized by journal and article, represent the research output in Count and Share according to the subject or journal group selected above.
| Journal | Count | Share |
|---|---|---|
|
ACS Nano |
1 | 0.78 |
|
Advanced Functional Materials |
2 | 1.86 |
|
American Journal of Respiratory and Critical Care Medicine |
5 | 0.75 |
|
Analytical Chemistry |
1 | 0.33 |
|
Angewandte Chemie International Edition |
3 | 0.26 |
|
Annals of the Rheumatic Diseases |
2 | 0.47 |
|
Arthritis & Rheumatology |
4 | 2.37 |
|
Blood |
1 | 0.07 |
|
Cancer Cell |
1 | 0.30 |
|
Cancer Research |
1 | 0.09 |
|
Cell |
1 | 0.01 |
|
Chemical Science |
5 | 1.77 |
|
Chest |
1 | 0.10 |
|
Circulation |
2 | 0.91 |
|
Clinical Infectious Diseases |
1 | 0.08 |
|
European Heart Journal |
1 | 0.09 |
|
Journal of Biological Chemistry |
1 | 0.38 |
|
Journal of Cell Biology |
1 | 0.07 |
|
Journal of Clinical Investigation |
2 | 0.06 |
|
Journal of Clinical Oncology |
6 | 1.66 |
|
Journal of Infectious Diseases |
4 | 2.41 |
|
Journal of Thoracic and Cardiovascular Surgery |
1 | 0.29 |
|
Journal of the American Chemical Society |
1 | 0.14 |
|
Journal of the American College of Cardiology |
4 | 0.88 |
|
Journal of the American Society of Nephrology |
6 | 2.64 |
|
Kidney International |
1 | 0.55 |
|
Nature |
4 | 0.65 |
|
Nature Communications |
14 | 4.18 |
|
Nature Genetics |
2 | 0.05 |
|
Nature Immunology |
2 | 0.18 |
|
Nature Medicine |
4 | 0.89 |
|
PLOS Genetics |
1 | 0.27 |
|
PLOS Medicine |
1 | 0.08 |
|
Proceedings of the National Academy of Sciences of the United States of America |
2 | 0.69 |
|
The Journal of Allergy and Clinical Immunology |
2 | 1.36 |
|
The Lancet |
5 | 1.39 |
|
The Lancet Diabetes & Endocrinology |
1 | 0.15 |
|
The New England Journal of Medicine |
5 | 0.90 |
|
Thorax |
2 | 0.38 |
Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.